REPLIGEN CORP (RGEN) /

The cash flow of REPLIGEN CORP over the past 10 years

Chart REPLIGEN CORP: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, REPLIGEN CORP's operating cash flow was $117.42M and its capital expenditures $25.73M, leaving free cash flow of $91.69M. Free cash flow was above zero in all 10 years shown. It ranged from $3.2M in fiscal 2016 to $145.5M in fiscal 2024. Capital expenditures were highest in fiscal 2022, at $88.35M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$117.42M$25.73M*$91.69M
2024ended Dec 31, 2024$175.39M$29.9M*$145.5M
2023ended Dec 31, 2023$113.92M$38.99M*$74.93M
2022ended Dec 31, 2022$172.08M$88.35M*$83.74M
2021ended Dec 31, 2021$119.02M$71.28M*$47.74M
2020ended Dec 31, 2020$62.63M$26.34M*$36.28M
2019ended Dec 31, 2019$67.22M$23.15M*$44.06M
2018ended Dec 31, 2018$32.77M$14.04M*$18.73M
2017ended Dec 31, 2017$17.45M$5.45M$12M
2016ended Dec 31, 2016$7.52M$4.33M$3.2M

Fiscal years as REPLIGEN CORP reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on REPLIGEN CORP

Companies of a similar size

Not investment advice. This page shows what REPLIGEN CORP filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.